PRX302: Clinical Trials

7 trials of PRX302, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 5 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 12Completed 2
Phase 31Completed 1

Follow PRX302: new trials by email Literature Review of PRX302 trials Research Report on PRX302

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer
PRX302 - Prostate Cancer
Phase 2CompletedSophiris Bio Corp382017-06-072019-04-10
Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer
PRX302 - Prostate Cancer
Phase 2CompletedSophiris Bio Corp182015-07-012016-07-27
Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH
PRX302, Placebo - Benign Prostatic Hyperplasia
Phase 3CompletedSophiris Bio Corp4792013-10-012017-04-27
Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)
PRX302, Placebo - Benign Prostatic Hyperplasia
Phase 1 / Phase 2CompletedSophiris Bio Corp402011-09-012013-08-21
Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia
PRX302, Placebo - Benign Prostatic Hyperplasia
Phase 2CompletedSophiris Bio Corp922009-01-012018-11-21
An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy
PRX302 - Locally Recurrent Prostate Cancer
Phase 2CompletedSophiris Bio Corp302008-02-012009-10-29
PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer
PSA-Activated PSA-PAH1 - Prostate Cancer
Phase 1CompletedSophiris Bio Corp242006-03-012018-10-29

Conditions studied

Prostatic Neoplasms (4)  ·  Prostatic Hyperplasia (3)  ·  Lower Urinary Tract Symptoms (2)

Sponsors

Sophiris Bio Corp (7)

Countries

United States (5)  ·  Canada (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  New Zealand (1)  ·  Russia (1)  ·  Ukraine (1)

Top investigators

Hashim U Ahmed, MD (1)  ·  Hashim U Ahmed, PhD,FRCS (1)  ·  King S Coffield, M.D. (1)  ·  Mostafa Elhilali, MD (1)  ·  Peter Pommerville, MD (1)  ·  Richard C Yocum, MD (1)  ·  Richard C. Yocum, MD (1)